Everplay group reports in-line results, maintains FY26 guidance By Investing.com

Adjusted EBITDA rose 11% to £48.5m and margins expanded 310bps to 29.2% while revenue was flat at £166m; cash declined £11.0m to £51.9m after dividend payments and M&A. The board proposed a final dividend of 1.9p (total 2.9p) and confirmed FY26 guidance in line with consensus (consensus: revenues +5% to £174m; EBITDA +4% to £50.5m). Company expects increased capital development and amortization as it shifts toward first‑party IP, with at least 15 new releases (≥5 first‑party) planned; Team17 +8% to £106m, Astragon -33% (−18% ex-physical), StoryToys +25%, back catalogue -13% but +10% vs FY23, and new releases +80%.

Analysis

The company’s explicit pivot to own more first-party IP — funded by higher near-term capital development — is a classic hit-or-miss growth strategy: it compresses free cash flow and EBITDA margin in the short run but converts recurring royalty expense into higher-margin owned revenue over 18–36 months if even 1–2 titles land. With a 15-title slate (five first-party), Monte Carlo-style thinking implies the firm only needs one breakout (a top-quartile seller) to swing FY27 EBITDA materially higher; conversely, a subpar hit rate leaves leverage elevated and valuation vulnerable to multiple compression.

Operationally, the shift increases operational beta: dev capex peak means amortization and capitalized costs will create lumpy P&L and cash profiles, making quarterly guidance and release cadence the dominant short-term catalysts (next 3–9 months). The decision to retain payouts while doing M&A pulls down cash buffers — that raises refinancing or acquisitive dilution risk if releases underperform and management needs to buy growth or monetize IP at lower multiples within 12–24 months.

Second-order winners/losers: digital-first first-party studios, middleware/platform providers and IP aggregators are asymmetric beneficiaries as royalty leakage shrinks; physical distributors, retailers and logistics chains tied to boxed sales are secular losers as mix shifts. Key downside triggers are a clustered release failure (2–3 flops in 6–9 months), adverse FX movements on localized revenue, or unexpectedly long dev cycles that push the capital peak into FY27, reversing the near-term margin narrative.

Key Decisions for Investors

• Long selective mid-cap first-party exposure: TM17.L (Team17) — buy the stock or Dec-2026 calls if available. Timeframe: 9–12 months. R/R: target 20–35% upside if catalogue strength and new releases keep momentum; hedge with a 30–40% OTM 9–12 month put to cap downside from a systemic gaming sell-off. Size: modest (2–4% of equity book) given single-title binary risk.
• Pair trade to play structural mix shift: Long TTWO (Take-Two) 12 months / Short GME (GameStop) 6–9 months. Timeframe: 6–12 months. R/R: expect TTWO to outperform by 20–30% as owned-IP monetization outpaces physical retail decline; ratio size 1:0.5 (equity dollar-neutral) to account for volatility mismatch. Stop-loss: 15% on either leg if divergence reverses.
• Event-driven play on consolidation/upside optionality: EMBRAC B (Embracer) — buy the stock or Jan-2027 calls to express M&A-led IP aggregation upside. Timeframe: 12–24 months. R/R: asymmetric upside if management executes tuck-ins and leverages back catalogue; downside risk is elevated leverage and integration misses — cap position size and consider selling short-dated calls to finance premium if conviction is moderate.